This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Nadim Akhtar, PhD
Principal Scientist at AstraZeneca
Speaker

Profile

Nadim Akhtar, Ph.D., is a Senior Principal Scientist in the Global Product Development in Pharmaceutical Technology and Development (PT&D) function at AstraZeneca. Nadim has been working for AstraZeneca since 2005. During this time Nadim has worked on both early and late-stage portfolio supporting development and commercialisation of small molecules and new modalities i.e., oligonucleotides, peptides, polymeric nanoparticles, dendrimers, and mRNA products. Nadim is currently responsible for developing characterisation and control strategies for New Modalities.

Agenda Sessions

  • Workshop Moderator's Welcome and Opening Remarks

    09:00
  • Leveraging Digital to Accelerate Oligonucleotide Development

    09:05